{{Rsnum
|rsid=11668609
|Chromosome=19
|position=24172691
|Orientation=plus
|GMAF=0.3274
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 3.5 | 31.9 | 64.6
| HCB | 3.7 | 41.2 | 55.1
| JPT | 4.4 | 45.1 | 50.4
| YRI | 38.1 | 48.3 | 13.6
| ASW | 26.3 | 57.9 | 15.8
| CHB | 3.7 | 41.2 | 55.1
| CHD | 6.4 | 38.5 | 55.0
| GIH | 5.0 | 28.7 | 66.3
| LWK | 43.6 | 45.5 | 10.9
| MEX | 8.6 | 44.8 | 46.6
| MKK | 41.0 | 44.9 | 14.1
| TSI | 0.0 | 41.2 | 58.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=3E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}